AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-288 Cr | ₹122 Cr | ₹122 Cr | ₹128 Cr | ₹98 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of AUROBINDO PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹-288 Cr |
Mar2022 | ₹122 Cr |
Mar2021 | ₹122 Cr |
Mar2020 | ₹128 Cr |
Mar2019 | ₹98 Cr |
How is Deferred Tax Assets / Liabilities of AUROBINDO PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹-288 Cr | Negative | |
Mar2022 | ₹122 Cr | 0.40 | |
Mar2021 | ₹122 Cr | -5.14 | |
Mar2020 | ₹128 Cr | 31.09 | |
Mar2019 | ₹98 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹67,536.7 Cr | 1.9% | 3.6% | 87.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 1.9% |
3.6% |
87.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses